BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8738877)

  • 1. Corticostatins/defensins inhibit in vitro NK activity and cytokine production by human peripheral blood mononuclear cells.
    Masera RG; Bateman A; Muscettola M; Solomon S; Angeli A
    Regul Pept; 1996 Apr; 62(1):13-21. PubMed ID: 8738877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro effects of peptides of the corticostatin/defensin family on production of mitogen-induced cytokines].
    Masera RG; Muscettola M; Tanganelli C; Grasso G; Bateman A; Solomon S; Angeli A
    Ann Ital Med Int; 1995; 10(2):113-8. PubMed ID: 7619650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The autocrine-paracrine modulation of natural killer activity in man by peptides of the corticostatin-defensin family].
    Masera RG; Gatti G; Bateman A; Solomon S; Sartori ML; Staurenghi A; Lazzero A; Griot G; Angeli A
    Ann Ital Med Int; 1993; 8(2):80-5. PubMed ID: 8353023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity.
    Gatti G; Masera RG; Pallavicini L; Sartori ML; Staurenghi A; Orlandi F; Angeli A
    Brain Behav Immun; 1993 Mar; 7(1):16-28. PubMed ID: 8386029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of CRH, ACTH and the corticostatin HP-4 on the spontaneous NK cell activity and susceptibility to endogenous modifiers.
    Gatti G; Masera RG; Bateman A; Sartori ML; Pallavicini L; Maina L; Staurenghi A; Solomon S; Angeli A
    Arch Gerontol Geriatr; 1992; 15 Suppl 1():159-71. PubMed ID: 18647686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell activity in the peripheral blood of patients with Cushing's syndrome.
    Masera RG; Staurenghi A; Sartori ML; Angeli A
    Eur J Endocrinol; 1999 Apr; 140(4):299-306. PubMed ID: 10097248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary-adrenal axis function, psychopathological traits, and natural killer (NK) cell activity in anorexia nervosa.
    Staurenghi AH; Masera RG; Prolo P; Griot G; Sartori ML; Ravizza L; Angeli A
    Psychoneuroendocrinology; 1997 Nov; 22(8):575-90. PubMed ID: 9483703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
    Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
    Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.
    D'Andrea A; Rengaraju M; Valiante NM; Chehimi J; Kubin M; Aste M; Chan SH; Kobayashi M; Young D; Nickbarg E
    J Exp Med; 1992 Nov; 176(5):1387-98. PubMed ID: 1357073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.
    Aste-Amezaga M; D'Andrea A; Kubin M; Trinchieri G
    Cell Immunol; 1994 Jul; 156(2):480-92. PubMed ID: 7912999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
    Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
    Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of methylcobalamin (vitamin B12) on in vitro cytokine production of peripheral blood mononuclear cells.
    Yamashiki M; Nishimura A; Kosaka Y
    J Clin Lab Immunol; 1992; 37(4):173-82. PubMed ID: 1339917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells.
    Pintaric M; Gerner W; Saalmüller A
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):68-82. PubMed ID: 17913242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
    Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
    J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation and biological activity of interleukin 12.
    Lee SM; Suen Y; Qian J; Knoppel E; Cairo MS
    Leuk Lymphoma; 1998 May; 29(5-6):427-38. PubMed ID: 9643557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, IFN-gamma, IL-6): role of the nitric oxide-L-arginine pathway.
    Santarelli L; Bracci M; Mocchegiani E
    Int Immunopharmacol; 2006 Mar; 6(3):376-89. PubMed ID: 16428073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of natural killer cytotoxic factor in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Agostini C; Chisesi T; Vespignani M; Pizzolo G; Pandolfi F; Ensoli F; Semenzato G
    Leuk Res; 1989; 13(4):315-22. PubMed ID: 2497276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.